{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"lipoprotein-glomerulopathy","columns":[{"gene":"","key":"population-07aa317dcf134e0a992c","label":"Lipoprotein glomerulopathy","mondoId":"MONDO:0012725","onsetQualifier":null,"originColumnKey":"MONDO:0012725/OMIM:611771","originalViews":[{"key":"MONDO:0012725/OMIM:611771","label":"Lipoprotein glomerulopathy","scopeLabel":"OMIM:611771","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["4b6f03fb4dd5184f8cf2e48f65a3184450629bcd36a3a59d3df36907a28e3cb4","5f7afcee0739452f97f6163c494ab2cef909e54f6b207f26b1dce3c764e3b964","ab52971d517ce7e8ccade1d70286819e254f1363a53f217e86d2327b715fb1d8","e1b418c76c177b13238062c2785b7399f1b68abf33ef9a723d9d6a09b83f0bdf"],"recordQualifiers":{},"scopeLabel":"OMIM:611771","sourceIds":["OMIM:611771"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-07aa317dcf134e0a992c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100820","HP:0012574","HP:0000093","HP:0000083"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":4,"sourceGroups":{"published":4}},"features":[{"hpoId":"HP:0100820","label":"Glomerulopathy","primary":true},{"hpoId":"HP:0012574","label":"Mesangial hypercellularity","primary":true},{"hpoId":"HP:0000093","label":"Proteinuria","primary":true},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":true}],"ledeHtml":"A rare genetic renal disease characterized by the formation of intraglomerular lipoprotein thrombi due to lipid deposition in severely dilated glomerular capillaries. Laboratory examination reveals abnormal serum lipid profiles, in particular markedly elevated apolipoprotein E. Clinical manifestations include proteinuria or nephrotic syndrome with hypertension and potential progression to chronic renal failure. Systemic complications of dyslipidemia are not observed.","mondoId":"MONDO:0012725","node":{"canonicalSlug":"lipoprotein-glomerulopathy","comparisons":[{"documentSha256":"08c5216e2efa2ffbd381408b4602479dbd9fd02c5e832750c5742a6fe3186b0c","key":"legacy-lipoprotein-glomerulopathy","kind":"legacy","label":"lipoprotein glomerulopathy","memberIds":["MONDO:0012725"],"mondoId":"MONDO:0012725","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/lipoprotein-glomerulopathy.08c5216e2efa2ffbd381408b4602479dbd9fd02c5e832750c5742a6fe3186b0c.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Lipoprotein glomerulopathy","originalSourceId":"ORPHA:329481","paragraphs":["A rare genetic renal disease characterized by the formation of intraglomerular lipoprotein thrombi due to lipid deposition in severely dilated glomerular capillaries. Laboratory examination reveals abnormal serum lipid profiles, in particular markedly elevated apolipoprotein E. Clinical manifestations include proteinuria or nephrotic syndrome with hypertension and potential progression to chronic renal failure. Systemic complications of dyslipidemia are not observed."],"rawAttribution":"ORPHA:329481","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:34Z","upstream":"ORPHA:329481","url":"https://rarediseases.info.nih.gov/diseases/17504"},"ownColumnKeys":["population-07aa317dcf134e0a992c"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic dyslipidemia","mondoId":"MONDO:0015905","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"4b6f03fb4dd5184f8cf2e48f65a3184450629bcd36a3a59d3df36907a28e3cb4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:611771","disease_name":"Lipoprotein glomerulopathy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100820","is_excluded":false,"label":"Glomerulopathy","onset_id":null,"reference":"PMID:18077821","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5f7afcee0739452f97f6163c494ab2cef909e54f6b207f26b1dce3c764e3b964","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:611771","disease_name":"Lipoprotein glomerulopathy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012574","is_excluded":false,"label":"Mesangial hypercellularity","onset_id":null,"reference":"PMID:10432380","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ab52971d517ce7e8ccade1d70286819e254f1363a53f217e86d2327b715fb1d8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:611771","disease_name":"Lipoprotein glomerulopathy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"PMID:18077821","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e1b418c76c177b13238062c2785b7399f1b68abf33ef9a723d9d6a09b83f0bdf","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:611771","disease_name":"Lipoprotein glomerulopathy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:18077821","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17504\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:329481</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic renal disease characterized by the formation of intraglomerular lipoprotein thrombi due to lipid deposition in severely dilated glomerular capillaries. Laboratory examination reveals abnormal serum lipid profiles, in particular markedly elevated apolipoprotein E. Clinical manifestations include proteinuria or nephrotic syndrome with hypertension and potential progression to chronic renal failure. Systemic complications of dyslipidemia are not observed.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17504\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"lipoprotein-glomerulopathy","sourceDocuments":[{"name":"GARD: Lipoprotein glomerulopathy","reviewed":null,"source_release":"2026-10-21T17:02:34Z","url":"https://rarediseases.info.nih.gov/diseases/17504"}],"sourceNote":"","synonyms":["lipoprotein glomerulopathy","LPG"],"takeawayHtml":"","title":"lipoprotein glomerulopathy"},"schemaVersion":1}
